Nolato Ab Class B · OMXSTO:NOLA_B
Nolato Ab Class B — Q3 2023 Earnings Presentation
15 slides from Nolato Ab Class B's earnings presentation, Oct 26, 2023
Slide 1: Third quarter
Medical Solutions Third quarter Integrated Solutions CEO Christer Wahlquist CFO Per-Ola Holmström Industrial Solutions October 26, 2023
Slide 2: Q3 summary
Q3 summary A global solutions provider established on three continents Group Growth across ● Sales totaled SEK 2,340 million (2,626) Group - Positive currency effect; a 15% decrease SEKm adjusted for currency and acquisitions - Increased sales for Medical and Industrial Solutions 12000 Balancing 110
Slide 3: One Group – three business areas
One Group – three business areas Nolato Medical Solutions Integrated Solutions Industrial Solutions Our offering as a strategic partner for selected Development and manufacture of Design, development and Development and manufacture of global customers comprises development and complex product system
Slide 4: Medical Solutions – Sustainable Growth and Global expansion
Medical Solutions – Sustainable Growth and Global expansion SEKm 5500 5000 4500 4000 3500 3000 126 EBITA 2500 2000 1,320 SEKm, Q3 1500 1000 9.5 SALES SEKm, Q3 500 EBITA MARGIN 0 %, Q3 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 LTM 4
Slide 5: Medical Solutions – Focused product areas
Medical Solutions – Focused product areas Pharma Diagnostics Medical Devices Drug Delivery ~14% In Vitro Diagnostics (IVD) ~15% Endoscopy & General Surgery ~22% Cardiology ~8% Continence care ~11% Pharma Packaging ~13% Other ~17% 5
Slide 6: Medical Solutions – Q3
Medical Solutions – Q3 Q3 Acc. 9 months ● 6% increase in sales SEKm 2023 2022 2023 2022 - Increase of 1% adjusted for currency - Continued inventory adjustments and change in the customer mix in IVD Sales 1,320 1,245 4,008 3,547 - Somewhat lower volumes in the surgery area Operating profit (EBITA) 1
Slide 7: Integrated Solutions – Expansion into new market segments
Integrated Solutions – Expansion into new market segments SEKm 5500 5000 4500 4000 3500 10 EBITA 3000 2500 330 SEKm, Q3 2000 1500 3.0 SALES 1000 SEKm, Q3 500 EBITA MARGIN %, Q3 0 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 LTM 7
Slide 8: Integrated Solutions – Focused product areas
Integrated Solutions – Focused product areas Consumer Electronics EMC & Thermal Trishield - Dispensing Gaskets Complex Modules Speakers Compashield - Extrusion & Molded Gaskets VHP MIL SPEC EMI Shielding In/On/Over Ear Headphones - Aerospace & Defence Wearable & Handheld Wellbeing Devices Thermal In
Slide 9: Integrated Solutions – Q3
Integrated Solutions – Q3 Q3 Acc. 9 months ● 56% decrease in sales - A decrease of some 57% adjusted for currency and acquisitions SEKm 2023 2022 2023 2022 - Low volumes and a change in sourcing strategy at a previously significant customer had a negative impact Sales 330 745 1,136 2,904 - EMC sales
Slide 10: Industrial Solutions – Technological and geographical expansion
Industrial Solutions – Technological and geographical expansion SEKm 3000 2800 2600 2400 2200 2000 1800 64 1600 1400 691 EBITA 1200 SEKm, Q3 1000 800 9.3 SALES SEKm, Q3 600 400 EBITA MARGIN 200 %, Q3 0 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 LTM 10
Slide 11: Industrial Solutions – Focused product areas
Industrial Solutions – Focused product areas Domestic appliances Packaging Hygiene Gardening/forestry Furniture sectors Automotive Other selected industrial segments 11
Slide 12: Industrial Solutions – Q3
Industrial Solutions – Q3 ● 8% increase in sales Q3 Acc. 9 months - Increase of 2% adjusted for currency - Volumes in automotive have risen and supply chain disruptions have had less SEKm 2023 2022 2023 2022 of an impact than previously - Demand for products in consumer discretionary sector slightly
Slide 13: Group financial highlights
Group financial highlights Q3 Acc. 9 months Full year SEKm 2023 2022 2023 2022 R-12 2022 Net sales 2,340 2,626 7,294 8,410 9,658 10,774 Operating profit (EBITA)*) 133 214 524 745 687 908 Operating profit (EBITA), excl. a non-recurring item 2023 193 214 584 745 747 908 EBITA margin (%), excl. a non-r
Slide 14: Current situation
Current situation Medical Solutions Integrated Solutions Industrial Solutions • Maintained growth strategy • Established position in new product • Advanced market positions areas • Focus on margins • Emphasis on sustainable solutions • Success in automotive area • Innovation and sustainability • Gen
Slide 15: Thank you.
Thank you. This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncertainties pertaini